Raffa j (27 Ergebnisse)

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings. In good all round condition. Dust jacket in good condition. Library sticker on front cover. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,500grams, ISBN:0864450346.…

Zustand: Very Good. published by CRC Press 2013, hardback. Little wear and grub marks from sticker residue to back board, pages in very nice condition, shipped from the UK.

Paperback. Zustand: Brand New. 1st edition. 54 pages. 8.50x8.50x0.13 inches. In Stock.

Zustand: New.

Zustand: New. In English.

Zustand: New.

Zustand: New.

Paperback. Zustand: Brand New. 152 pages. 9.21x6.14x0.32 inches. In Stock.

Paperback. Zustand: Brand New. reprint edition. 221 pages. 9.50x6.50x0.75 inches. In Stock.

Zustand: New. In English.

Zustand: New. 2019. 1st Edition. paperback. . . . . . Books ship from the US and Ireland.

Zustand: New. Robert B. Raffa, Ph.D. is Professor and Chair within the Department of Pharmaceutical Sciences at Temple University School of Pharmacy, in Philadelphia, Pennsylvania.Ronald J. Tallarida, Ph.D. is Professor of Pharmacology at Temple Universi.

Einband - fest (Hardcover). Zustand: New.

Zustand: New.

Gebunden. Zustand: New.

Zustand: New. In English.

Zustand: New.

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. Due to the advances in chemotherapy and other aspects of prevention, early detection, and treatment modalities, an increasing percentage of patients are surviving the disease. For some types of cancer, the majority of patients live decades beyond their diagnosis. For this they are forever thankful and appreciative of the drugs that helped lead to this increased survival rate. But no drug is devoid of adverse effects. This also applies to chemotherapeutic agents. The acute cytotoxic effects of these agents are well known--indeed are often required for their therapeutic benefit. The chronic adverse effects are varied and in some cases less well known. With the increase in survival rates, there has emerged a new awareness of these chronic adverse effects.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. Due to the advances in chemotherapy and other aspects of prevention, early detection, and treatment modalities, an increasing percentage of patients are surviving the disease. For some types of cancer, the majority of patients live decades beyond their diagnosis. For this they are forever thankful and appreciative of the drugs that helped lead to this increased survival rate. But no drug is devoid of adverse effects. This also applies to chemotherapeutic agents. The acute cytotoxic effects of these agents are well known--indeed are often required for their therapeutic benefit. The chronic adverse effects are varied and in some cases less well known. With the increase in survival rates, there has emerged a new awareness of these chronic adverse effects.…

Taschenbuch. Zustand: Neu. Chemo Fog | Cancer Chemotherapy-Related Cognitive Impairment | Robert B. Raffa (u. a.) | Taschenbuch | xxi | Englisch | 2016 | Springer | EAN 9781493940998 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Zustand: New. In English.

Paperback. Zustand: Brand New. reprint edition. 216 pages. 10.00x7.01x0.55 inches. In Stock.

Hardcover. Zustand: Brand New. illustrated edition. 216 pages. 10.00x6.50x0.50 inches. In Stock.

Hardcover. Zustand: Brand New. 152 pages. 9.21x6.14x0.55 inches. In Stock.

Gebunden. Zustand: New. Robert B. Raffa, Ph.D. is Professor and Chair within the Department of Pharmaceutical Sciences at Temple University School of Pharmacy, in Philadelphia, Pennsylvania.Ronald J. Tallarida, Ph.D. is Professor of Pharmacology at Temple Universi.

Buch. Zustand: Neu. Neuware - There have been tremendous recent advances in the pharmacotherapy, dose regimens, and combinations used to treat cancer and for the treatment or prevention of the spread of disease. As a direct result of these advances, there are an increasing number of cancer survivors, although research dealing with chemotherapy-induced pain is still in its early years. Written for pain management specialists, oncologists, pharmacologists, students, and primary care practitioners, Chemotherapy-Induced Neuropathic Pain provides insight into the important area of chemotherapy-induced neuropathic pain. It reviews the basic and clinical research into the normal physiology of pain transmission pathways, neuropathic pain pathology, the chemotherapeutic drug mechanisms of action and adverse effects, chemotherapy-induced neuropathy, and drug discovery efforts for treatment. The contributors comprise an impressive list of clinical and basic science experts in the fields of pain mechanisms and pain management.Included are clinical directors of pain clinics and clinical research facilities, directors of large academic pain research laboratories, analgesic drug developers, and presidents of the International Association for the Study of Pain (IASP), Association of Chronic Pain Patients (ACPP), and the British Pain Society (BPS). Through them, the book provides the reader with an exceptional opportunity to acquire a fundamental understanding of the basic concepts related to this topic.…